236 related articles for article (PubMed ID: 15039332)
1. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein.
Fulton SA; Reba SM; Pai RK; Pennini M; Torres M; Harding CV; Boom WH
Infect Immun; 2004 Apr; 72(4):2101-10. PubMed ID: 15039332
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection.
Pecora ND; Fulton SA; Reba SM; Drage MG; Simmons DP; Urankar-Nagy NJ; Boom WH; Harding CV
Cell Immunol; 2009; 254(2):94-104. PubMed ID: 18762288
[TBL] [Abstract][Full Text] [Related]
3. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
5. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
Xu Z; Xia A; Li X; Zhu Z; Shen Y; Jin S; Lan T; Xie Y; Wu H; Meng C; Sun L; Yin Y; Chen X; Jiao X
BMC Immunol; 2018 Jun; 19(1):19. PubMed ID: 29940854
[TBL] [Abstract][Full Text] [Related]
6. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
8. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin modulation of BCG-infected dendritic cell functions.
Hwang SA; Actor JK
Int Immunol; 2009 Oct; 21(10):1185-97. PubMed ID: 19692539
[TBL] [Abstract][Full Text] [Related]
11. I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M. bovis BCG.
Barrera LF; Kramnik I; Skamene E; Radzioch D
Mol Immunol; 1997 Mar; 34(4):343-55. PubMed ID: 9244347
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production.
Lagranderie M; Nahori MA; Balazuc AM; Kiefer-Biasizzo H; Lapa e Silva JR; Milon G; Marchal G; Vargaftig BB
Immunology; 2003 Mar; 108(3):352-64. PubMed ID: 12603602
[TBL] [Abstract][Full Text] [Related]
14. Interaction of antigen presenting cells with mycobacteria.
Hope JC; Thom ML; McCormick PA; Howard CJ
Vet Immunol Immunopathol; 2004 Aug; 100(3-4):187-95. PubMed ID: 15207456
[TBL] [Abstract][Full Text] [Related]
15. TNFRp75-dependent immune regulation of alveolar macrophages and neutrophils during early Mycobacterium tuberculosis and Mycobacterium bovis BCG infection.
Walters A; Keeton R; Labuschagné A; Hsu NJ; Jacobs M
Immunology; 2021 Feb; 162(2):220-234. PubMed ID: 33020922
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.
Schreiber HA; Hulseberg PD; Lee J; Prechl J; Barta P; Szlavik N; Harding JS; Fabry Z; Sandor M
PLoS One; 2010 Jul; 5(7):e11453. PubMed ID: 20625513
[TBL] [Abstract][Full Text] [Related]
17. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
18. BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.
Bakhru P; Sirisaengtaksin N; Soudani E; Mukherjee S; Khan A; Jagannath C
Cell Immunol; 2014 Jan; 287(1):53-61. PubMed ID: 24384074
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation.
Ramachandra L; Qu Y; Wang Y; Lewis CJ; Cobb BA; Takatsu K; Boom WH; Dubyak GR; Harding CV
Infect Immun; 2010 Dec; 78(12):5116-25. PubMed ID: 20837713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]